Millennium Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Buy |
165,800
+105,200
| +174% | +$8.42M | ﹤0.01% | 2136 |
|
|
2025
Q4 | $5.78M | Buy |
60,600
+16,400
| +37% | +$1.61M | ﹤0.01% | 2852 |
|
|
2025
Q3 | $4.32M | Sell |
44,200
-274,500
| -86% | -$28.4M | ﹤0.01% | 3289 |
|
|
2025
Q2 | $34.2M | Sell |
318,700
-487,500
| -60% | -$49.3M | 0.02% | 1083 |
|
|
2025
Q1 | $81.3M | Buy |
806,200
+98,700
| +14% | +$9.94M | 0.04% | 465 |
|
|
2024
Q4 | $63.2M | Buy |
707,500
+28,500
| +4% | +$2.51M | 0.03% | 650 |
|
|
2024
Q3 | $56.9M | Sell |
679,000
-566,000
| -45% | -$44.6M | 0.03% | 754 |
|
|
2024
Q2 | $95.9M | Buy |
1,245,000
+359,900
| +41% | +$26.3M | 0.04% | 450 |
|
|
2024
Q1 | $60.6M | Sell |
885,100
-911,700
| -51% | -$58.6M | 0.03% | 707 |
|
|
2023
Q4 | $104M | Buy |
1,796,800
+302,300
| +20% | +$16.1M | 0.04% | 403 |
|
|
2023
Q3 | $78.9M | Buy |
1,494,500
+145,400
| +11% | +$7.63M | 0.04% | 477 |
|
|
2023
Q2 | $73M | Buy |
1,349,100
+3,700
| +0.3% | +$193K | 0.04% | 505 |
|
|
2023
Q1 | $67.3M | Buy |
1,345,400
+75,000
| +6% | +$3.53M | 0.04% | 521 |
|
|
2022
Q4 | $58.8M | Buy |
1,270,400
+252,900
| +25% | +$11M | 0.03% | 660 |
|
|
2022
Q3 | $39.4M | Buy |
1,017,500
+482,200
| +90% | +$19.3M | 0.02% | 827 |
|
|
2022
Q2 | $20M | Buy |
535,300
+202,100
| +61% | +$8.23M | 0.01% | 1310 |
|
|
2022
Q1 | $14.8M | Sell |
333,200
-257,600
| -44% | -$11.2M | 0.01% | 1704 |
|
|
2021
Q4 | $25.1M | Sell |
590,800
-50,000
| -8% | -$2.1M | 0.01% | 1236 |
|
|
2021
Q3 | $27.8M | Buy |
640,800
+130,000
| +25% | +$5.75M | 0.02% | 1034 |
|
|
2021
Q2 | $21.8M | Buy |
510,800
+97,800
| +24% | +$4.11M | 0.01% | 1122 |
|
|
2021
Q1 | $16M | Buy |
413,000
+177,300
| +75% | +$6.71M | 0.01% | 1300 |
|
|
2020
Q4 | $8.47M | Buy |
235,700
+108,100
| +85% | +$3.9M | 0.01% | 1917 |
|
|
2020
Q3 | $4.88K | Buy |
127,600
+67,300
| +112% | +$2.59M | 0.01% | 1862 |
|
|
2020
Q2 | $2.12M | Sell |
60,300
-23,600
| -28% | -$850K | ﹤0.01% | 2486 |
|
|
2020
Q1 | $2.74M | Sell |
83,900
-116,200
| -58% | -$4.54M | 0.01% | 1785 |
|
|
2019
Q4 | $9.05M | Sell |
200,100
-32,300
| -14% | -$1.35M | 0.01% | 1460 |
|
|
2019
Q3 | $9.46M | Buy |
232,400
+138,100
| +146% | +$5.85M | 0.01% | 1318 |
|
|
2019
Q2 | $4.05M | Buy |
94,300
+44,300
| +89% | +$1.7M | 0.01% | 1939 |
|
|
2019
Q1 | $1.92M | Hold |
50,000
| – | – | ﹤0.01% | 2439 |
|
|
2018
Q4 | $1.77M | Hold |
50,000
| – | – | ﹤0.01% | 2266 |
|
|
2018
Q3 | $1.93M | Sell |
50,000
-880,000
| -95% | -$30.7M | ﹤0.01% | 2460 |
|
|
2018
Q2 | $30.4M | Buy |
+930,000
| New | +$28M | 0.04% | 645 |
|
|
2017
Q4 | – | Sell |
-50,000
| Closed | -$1.46M | – | 3799 |
|
|
2017
Q3 | $1.46M | Sell |
50,000
-300,000
| -86% | -$8.28M | ﹤0.01% | 2328 |
|
|
2017
Q2 | $9.7M | Buy |
350,000
+250,000
| +250% | +$6.63M | 0.02% | 1077 |
|
|
2017
Q1 | $2.49M | Buy |
+100,000
| New | +$2.43M | ﹤0.01% | 1881 |
|
|
2016
Q2 | – | Sell |
-125,000
| Closed | -$2.35M | – | 3184 |
|
|
2016
Q1 | $2.35M | Buy |
+125,000
| New | +$2.2M | 0.01% | 1687 |
|
|
2015
Q2 | – | Sell |
-14,600
| Closed | -$259K | – | 3343 |
|
|
2015
Q1 | $259K | Buy |
14,600
+3,900
| +36% | +$61.6K | ﹤0.01% | 3132 |
|
|
2014
Q4 | $142K | Buy |
+10,700
| New | +$137K | ﹤0.01% | 3720 |
|
|
2014
Q1 | – | Sell |
-162,200
| Closed | -$1.95M | – | 3461 |
|
|
2013
Q4 | $1.95M | Buy |
+162,200
| New | +$1.92M | 0.01% | 1843 |
|
Other funds holding BSX
VCM
VPM
Millennium Management's BSX Position: Q1 2026 in Review
Millennium Management reduced its Boston Scientific (BSX) stake by 61% in Q1 2026, selling an estimated $554M and leaving 4,337,804 shares worth $241M. The position accounts for 0.1% of the portfolio, ranked #172.
Millennium Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.03B in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Millennium Management held 4,337,804 shares of Boston Scientific worth $241M as of Q1 2026.
- Millennium Management sold 6,926,986 Boston Scientific shares in Q1 2026, an estimated $554M.
- Boston Scientific made up 0.1% of Millennium Management's portfolio in Q1 2026, its #172 holding.
- Millennium Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Boston Scientific position peaked at $1.03B in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.